Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?
- PMID: 17854503
- PMCID: PMC2082274
- DOI: 10.1186/1747-1028-2-26
Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?
Abstract
Biochemical analysis of the retinoblastoma protein's function has received considerable attention since it was cloned just over 20 years ago. During this time pRB has emerged as a key regulator of the cell division cycle and its ability to block proliferation is disrupted in the vast majority of human cancers. Much has been learned about the regulation of E2F transcription factors by pRB in the cell cycle. However, many questions remain unresolved and researchers continue to explore this multifunctional protein. In particular, understanding how its biochemical functions contribute to its role as a tumor suppressor remains to be determined. Since pRB has been shown to function as an adaptor molecule that links different proteins together, or to particular promoters, analyzing pRB by disrupting individual protein interactions holds tremendous promise in unraveling the intricacies of its function. Recently, crystal structures have reported how pRB interacts with some of its molecular partners. This information has created the possibility of rationally separating pRB functions by studying mutants that disrupt individual binding sites. This review will focus on literature that investigates pRB by isolating functions based on binding sites within the pocket domain. This article will also discuss the prospects for using this approach to further explore the unknown functions of pRB.
Figures





Similar articles
-
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.Genes Dev. 1998 Jan 1;12(1):95-106. doi: 10.1101/gad.12.1.95. Genes Dev. 1998. PMID: 9420334 Free PMC article.
-
Retinoblastoma protein partners.Adv Cancer Res. 2001;82:1-54. doi: 10.1016/s0065-230x(01)82001-7. Adv Cancer Res. 2001. PMID: 11447760 Review.
-
Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.Oncogene. 2005 May 26;24(23):3810-8. doi: 10.1038/sj.onc.1208539. Oncogene. 2005. PMID: 15806172
-
pRB, p107 and the regulation of the E2F transcription factor.J Cell Sci Suppl. 1994;18:81-7. doi: 10.1242/jcs.1994.supplement_18.12. J Cell Sci Suppl. 1994. PMID: 7883798 Review.
-
The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.J Virol. 1993 Apr;67(4):2402-7. doi: 10.1128/JVI.67.4.2402-2407.1993. J Virol. 1993. PMID: 8445736 Free PMC article.
Cited by
-
Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition.Cell Cycle. 2012 Sep 1;11(17):3324-30. doi: 10.4161/cc.21693. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22895174 Free PMC article.
-
LXCXE-independent chromatin remodeling by Rb/E2f mediates neuronal quiescence.Cell Cycle. 2013 May 1;12(9):1416-23. doi: 10.4161/cc.24527. Epub 2013 Apr 9. Cell Cycle. 2013. PMID: 23574720 Free PMC article.
-
p107 in the public eye: an Rb understudy and more.Cell Div. 2010 Apr 2;5:9. doi: 10.1186/1747-1028-5-9. Cell Div. 2010. PMID: 20359370 Free PMC article.
-
HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.FEBS J. 2014 Jul;281(13):3061-78. doi: 10.1111/febs.12843. Epub 2014 Jun 10. FEBS J. 2014. PMID: 24823443 Free PMC article.
-
pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.Cell Death Differ. 2013 May;20(5):755-64. doi: 10.1038/cdd.2013.6. Epub 2013 Feb 22. Cell Death Differ. 2013. PMID: 23429261 Free PMC article.
References
-
- Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12: 2245–2262. - PubMed
LinkOut - more resources
Full Text Sources